Compensation Committee Of Dyne News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Dyne Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed President and Chief Executive Officer

WALTHAM, Mass., March 27, 2024 Dyne Therapeutics, Inc. , a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically.

Johng coxAmy reillyDyne therapeutics incCompensation committee of dyneChief executive officerCompensation committeeStock incentive planNasdaq listing ruleNasdaq global select marketStock incentive

Dyne Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed President and Chief Executive Officer

Dyne Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed President and Chief Executive Officer
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Amy reillyJohng coxCompensation committee of dyneDyne therapeutics incNewly appointed presidentChief executiveChief executive officerCompensation committeeStock incentive planNasdaq listing ruleNasdaq global select marketStock incentive